Good work JodyP,
I didn't like what happended yesterday even though I got stopped out and managed to buy in a little lower (lucky I just happended to be around at the right time).
The response from OBJ sounds ridiculous but they have indeed dug a hole for themselves with regard to ASX declarations and company confidentiality agreements clearly at odds with each other.
If we are to hear about GSK in the near future it will be at the level of development collaboration or licensing or alliance of some type, but it clearly would not simply be an update on test results. GSK would have to relax their confidentiality requirements for this to happen and why would they ?
Whatever, bring it on.
- Forums
- ASX - By Stock
- WFL
- email query to obj, re ann's
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

email query to obj, re ann's, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online